• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性卵磷脂:胆固醇酰基转移酶缺乏与心血管疾病。

Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease.

机构信息

Center E. Grossi Paoletti, Department of Pharmacological Sciences, Università degli Studi di Milano, Via Balzaretti 9, 20133 Milano, Italy.

出版信息

Atherosclerosis. 2012 Jun;222(2):299-306. doi: 10.1016/j.atherosclerosis.2011.11.034. Epub 2011 Nov 28.

DOI:10.1016/j.atherosclerosis.2011.11.034
PMID:22189200
Abstract

The lecithin:cholesterol acyltransferase (LCAT) enzyme is responsible for the synthesis of cholesteryl esters in human plasma and plays a critical role in high density lipoprotein (HDL) metabolism. Genetic LCAT deficiency is a rare metabolic disorder characterized by low HDL cholesterol levels. This paper reviews the genetic and biochemical features of LCAT deficiency, highlighting the absence of enhanced preclinical atherosclerosis in carriers, despite the remarkably low HDL cholesterol.

摘要

卵磷脂胆固醇酰基转移酶(LCAT)酶负责人体血浆中胆固醇酯的合成,在高密度脂蛋白(HDL)代谢中发挥着关键作用。LCAT 遗传性缺乏是一种罕见的代谢紊乱,其特征是 HDL 胆固醇水平降低。本文综述了 LCAT 缺乏的遗传和生化特征,强调了尽管 HDL 胆固醇水平显著降低,但携带者中并未出现增强的临床前动脉粥样硬化。

相似文献

1
Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease.遗传性卵磷脂:胆固醇酰基转移酶缺乏与心血管疾病。
Atherosclerosis. 2012 Jun;222(2):299-306. doi: 10.1016/j.atherosclerosis.2011.11.034. Epub 2011 Nov 28.
2
Identification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia.在一名智利低α脂蛋白血症患者中鉴定和功能分析卵磷脂胆固醇酰基转移酶基因的错义突变。
Lipids Health Dis. 2019 Jun 5;18(1):132. doi: 10.1186/s12944-019-1045-0.
3
Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis.完整和部分卵磷脂胆固醇酰基转移酶缺乏症与动脉粥样硬化的相关性存在差异。
Circulation. 2018 Sep 4;138(10):1000-1007. doi: 10.1161/CIRCULATIONAHA.118.034706.
4
Very low levels of HDL cholesterol and atherosclerosis, a variable relationship--a review of LCAT deficiency.极低水平的高密度脂蛋白胆固醇与动脉粥样硬化:一种可变关系——卵磷脂胆固醇酰基转移酶缺乏症综述
Vasc Health Risk Manag. 2012;8:357-61. doi: 10.2147/VHRM.S29985. Epub 2012 Jun 5.
5
Familial lecithin:cholesterol acyltransferase deficiency: molecular analysis of a compound heterozygote: LCAT (Arg147 --> Trp) and LCAT (Tyr171 --> Stop).家族性卵磷脂:胆固醇酰基转移酶缺乏症:复合杂合子的分子分析:LCAT(精氨酸147→色氨酸)和LCAT(酪氨酸171→终止密码子)
Atherosclerosis. 1997 May;131(1):85-95. doi: 10.1016/s0021-9150(97)06079-6.
6
Proteinuria in early childhood due to familial LCAT deficiency caused by loss of a disulfide bond in lecithin:cholesterol acyl transferase.家族性 LCAT 缺乏症导致的早发性蛋白尿,其发病机制是卵磷脂胆固醇脂酰转移酶中二硫键的丢失。
Atherosclerosis. 2011 May;216(1):161-5. doi: 10.1016/j.atherosclerosis.2011.01.025. Epub 2011 Jan 21.
7
Patients with low HDL-cholesterol caused by mutations in LCAT have increased arterial stiffness.由 LCAT 基因突变引起的低 HDL-胆固醇患者的动脉僵硬度增加。
Atherosclerosis. 2012 Dec;225(2):481-5. doi: 10.1016/j.atherosclerosis.2012.09.022. Epub 2012 Sep 27.
8
Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease.获得性卵磷脂胆固醇酰基转移酶缺乏症是慢性肾脏病患者降低血浆高密度脂蛋白水平的主要因素。
J Intern Med. 2015 May;277(5):552-61. doi: 10.1111/joim.12290. Epub 2014 Aug 1.
9
Familial lecithin-cholesterol acyltransferase deficiency: biochemical characteristics and molecular analysis of a new LCAT mutation in a Polish family.家族性卵磷脂胆固醇酰基转移酶缺乏症:波兰一个家族中一种新的卵磷脂胆固醇酰基转移酶(LCAT)突变的生化特征及分子分析
Atherosclerosis. 2006 Apr;185(2):413-20. doi: 10.1016/j.atherosclerosis.2005.06.022. Epub 2005 Jul 26.
10
Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans.功能性卵磷脂:胆固醇酰基转移酶对人类有效的动脉粥样硬化保护作用并非必需。
Circulation. 2009 Aug 18;120(7):628-35. doi: 10.1161/CIRCULATIONAHA.108.818143.

引用本文的文献

1
High-density lipoproteins, Part 1. Epidemiology, antiatherogenic effects, and therapies designed to increase their serum levels.高密度脂蛋白,第1部分。流行病学、抗动脉粥样硬化作用以及旨在提高其血清水平的治疗方法。
Am J Prev Cardiol. 2025 Jul 21;23:101068. doi: 10.1016/j.ajpc.2025.101068. eCollection 2025 Sep.
2
Rescue of Familial Lecithin:Cholesterol Acyltranferase Deficiency Mutations with an Allosteric Activator.家族性卵磷脂:胆固醇酰基转移酶缺乏突变的变构激活剂拯救。
Mol Pharmacol. 2024 Sep 17;106(4):188-197. doi: 10.1124/molpharm.124.000932.
3
A combined observational and Mendelian randomization investigation reveals NMR-measured analytes to be risk factors of major cardiovascular diseases.
一项联合观察性研究和孟德尔随机化研究表明,NMR 测量的分析物是主要心血管疾病的风险因素。
Sci Rep. 2024 May 9;14(1):10645. doi: 10.1038/s41598-024-61440-5.
4
A High-Throughput NMR Method for Lipoprotein-X Quantification.一种用于脂蛋白-X 定量的高通量 NMR 方法。
Molecules. 2024 Jan 23;29(3):564. doi: 10.3390/molecules29030564.
5
Molecular Biomarkers for Cardiometabolic Disease: Risk Assessment in Young Individuals.用于心脏代谢疾病的分子生物标志物:年轻人的风险评估。
Circ Res. 2023 Jun 9;132(12):1663-1673. doi: 10.1161/CIRCRESAHA.123.322000. Epub 2023 Jun 8.
6
Influence of lecithin cholesterol acyltransferase alteration during different pathophysiologic conditions: A 45 years bibliometrics analysis.不同病理生理条件下卵磷脂胆固醇酰基转移酶改变的影响:一项45年的文献计量学分析。
Front Pharmacol. 2022 Dec 14;13:1062249. doi: 10.3389/fphar.2022.1062249. eCollection 2022.
7
High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives.高密度脂蛋白胆固醇外排能力与心血管疾病中的动脉粥样硬化:病理生理方面和药物治疗观点。
Cells. 2021 Mar 5;10(3):574. doi: 10.3390/cells10030574.
8
Progression of chronic kidney disease in familial LCAT deficiency: a follow-up of the Italian cohort.家族性 LCAT 缺乏症患者慢性肾脏病的进展:意大利队列研究的随访结果。
J Lipid Res. 2020 Dec;61(12):1784-1788. doi: 10.1194/jlr.P120000976. Epub 2020 Sep 30.
9
Low Plasma Lecithin: Cholesterol Acyltransferase (LCAT) Concentration Predicts Chronic Kidney Disease.低血浆卵磷脂:胆固醇酰基转移酶(LCAT)浓度可预测慢性肾脏病。
J Clin Med. 2020 Jul 18;9(7):2289. doi: 10.3390/jcm9072289.
10
Structural analysis of lecithin:cholesterol acyltransferase bound to high density lipoprotein particles.结合态高密度脂蛋白中卵磷脂胆固醇脂酰转移酶的结构分析。
Commun Biol. 2020 Jan 15;3(1):28. doi: 10.1038/s42003-019-0749-z.